A focused overview of EU Commission proposals to evolve MDR/IVDR after 10 years, covering simplification, innovation, Notified Body changes, and future regulatory expectations.
At the end of 2025, the European Commission published a series of legislative proposals aimed at refining and adapting the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), marking a decade since their original publication. These proposals seek to strengthen innovation, enhance EU market attractiveness, and improve predictability and transparency, while maintaining the highest standards of patient safety.
During this presentation the proposals and justifications will be explained by discussing the opportunities and challenges related to each recommended measure. Participants will gain clear insights into the evolving legislative landscape and what these changes may mean for future regulatory strategies in the EU.
Key topics include:
Abbott- Conway Park
675 N Field Dr
Lake Forest, IL
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].


CEO, AKRA TEAM
Dr. Bassil Akra is a distinguished leader in medical device and in-vitro diagnostic device regulation, with extensive expertise spanning R&D, manufacturing, testing, conformity assessment, and standards development. As Chief Executive Officer of AKRA TEAM since July 2021, he supports the various stakeholders in developing and executing compliant regulatory, clinical, and quality strategies in the EU, effectively bridging the language between legislators, notified bodies, and industry stakeholders. He also supports the various due diligence activities and court cases which require his independent and impartial subject matter expertise.
A recognized authority in the European medtech regulatory arena, Dr. Akra has been instrumental in shaping the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). His contributions to regulatory frameworks extend to active involvement in developing Medical Device Coordination Group (MDCG) guidance documents and participating in critical regulatory updates that continue to define industry standards and best practices. Dr. Akra contributed to the ongoing revision of the EU MDR and IVDR as an advisor during the survey initiated by the EU Commission and was contracted later when evaluating the impact of the proposed changes on the healthcare system.
Dr. Akra's impressive career includes nearly a decade of work at the largest notified body in the Union Market: TÜV SÜD Product Service, where he progressed from Product Specialist to Vice President, ultimately leading global strategic business development and focus teams across cardiovascular, orthopedic, active implantable, aesthetic, and clinical domains. His instrumental role in building Notified Body capabilities in these critical areas established him as a key architect of success for the organization. Prior to his regulatory career, he served as Head of the Research Group Tissue Engineering in the Department of Cardiac Surgery at Klinikum der Universität München for over eight years. In this role, he worked with key MedTech Industry and healthcare professionals on designing, testing, and developing innovation in the cardiovascular sector.
Currently, Dr. Akra holds multiple leadership positions, including Vice President of TEAM-PRRC, Chair of the Scientific Advisory Board at 3Aware, Co-Founder and Board Member at Raiana, Board Member at MEDDEVO, CEO of B2MAS Holding, Advisory Board Member at Milo Health, and Lecturer at TUM Munich.
We have completed our migration to a new platform and are pleased to introduce the updated site.
What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.
We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.
We welcome your feedback. Please let us know how we can continue to improve your experience.